10x Genomics Reports First Quarter 2024 Financial Results

PLEASANTON, Calif., April 30, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Revenue was $141.0 million for the first quarter, a 5% increase…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks